Retrospective rebates, discounts, and fees for brand medicines in US 2013-2015
This statistic depicts the retrospective rebates, discounts, and fees for brand medicines in the U.S. from 2013 to 2015, in billion U.S. dollars. In 2013, rebates and discounts to health plans, PBMs (pharmacy benefit managers), and entities in the pharmaceutical supply chain, stood at some 67 billion U.S. dollars.